Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2107 | 5136 | 46.2 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
296 | 3 | BREAST//BREAST CANCER//LYMPHEDEMA | 41323 |
2107 | 2 | LYMPHANGIOGENESIS//VEGF C//PODOPLANIN | 5136 |
1435 | 1 | LYMPHANGIOGENESIS//VEGF C//VEGFR 3 | 2668 |
7275 | 1 | CANCER ASSOCIATED FIBROBLASTS//JEFFERSON STEM CELL BIOL REGENERAT MED//MANCHESTER BREAST | 1387 |
21633 | 1 | FIBROCYTES//PROGRAM BIOREGULAT GENET//SERUM AMYLOID P | 411 |
25370 | 1 | PODOPLANIN//D2 40 ANTIBODY//AGGRUS | 283 |
27092 | 1 | OCCULT NEOPLASTIC CELLS//FIBROTIC FOCUS//OISO HOSP | 238 |
31678 | 1 | ENDMT//ENDOTHELIAL MESENCHYMAL TRANSITION//ENDOTHELIAL TO MESENCHYMAL TRANSITION | 149 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LYMPHANGIOGENESIS | authKW | 2379046 | 13% | 61% | 660 |
2 | VEGF C | authKW | 1110940 | 6% | 63% | 298 |
3 | PODOPLANIN | authKW | 924494 | 5% | 66% | 236 |
4 | CANCER ASSOCIATED FIBROBLASTS | authKW | 811140 | 5% | 58% | 236 |
5 | VEGFR 3 | authKW | 643538 | 3% | 70% | 154 |
6 | VASCULAR ENDOTHELIAL GROWTH FACTOR C | authKW | 548801 | 3% | 71% | 130 |
7 | LYMPHATIC ENDOTHELIAL CELLS | authKW | 438789 | 2% | 65% | 114 |
8 | VEGF D | authKW | 409411 | 2% | 73% | 95 |
9 | PROX1 | authKW | 384808 | 2% | 55% | 118 |
10 | LYVE 1 | authKW | 314617 | 2% | 65% | 82 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 22844 | 35% | 0% | 1808 |
2 | Pathology | 8195 | 12% | 0% | 606 |
3 | Cell Biology | 6474 | 20% | 0% | 1004 |
4 | Medicine, Research & Experimental | 1756 | 8% | 0% | 410 |
5 | Developmental Biology | 920 | 3% | 0% | 157 |
6 | Anatomy & Morphology | 911 | 2% | 0% | 103 |
7 | Hematology | 509 | 4% | 0% | 198 |
8 | Immunology | 448 | 6% | 0% | 327 |
9 | Peripheral Vascular Diseases | 385 | 3% | 0% | 170 |
10 | Physiology | 298 | 4% | 0% | 188 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL CANC BIOL | 275792 | 3% | 31% | 151 |
2 | JEFFERSON STEM CELL BIOL REGENERAT MED | 195003 | 1% | 75% | 44 |
3 | MANCHESTER BREAST | 129245 | 1% | 51% | 43 |
4 | EYE DIS DEV | 116224 | 1% | 67% | 29 |
5 | PROGRAM VIS SCI | 96098 | 1% | 56% | 29 |
6 | BREAKTHROUGH BREAST CANC UNIT | 70570 | 1% | 24% | 49 |
7 | CANC ENABLING SCI TECHNOLMANCHESTER H | 59928 | 0% | 92% | 11 |
8 | TRANSLAT CANC BIOL PROGRAM | 54260 | 1% | 35% | 26 |
9 | OISO HOSP | 48487 | 1% | 28% | 29 |
10 | TUMOUR ANGIOGENESIS PROGRAM | 45036 | 0% | 63% | 12 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYMPHOLOGY | 40051 | 2% | 8% | 85 |
2 | LYMPHATIC RESEARCH AND BIOLOGY | 18909 | 0% | 13% | 25 |
3 | AMERICAN JOURNAL OF PATHOLOGY | 5626 | 2% | 1% | 111 |
4 | ONCOLOGY REPORTS | 4193 | 2% | 1% | 85 |
5 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 3956 | 1% | 1% | 58 |
6 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 3696 | 0% | 4% | 15 |
7 | ADVANCES IN ANATOMY EMBRYOLOGY AND CELL BIOLOGY | 3540 | 0% | 6% | 10 |
8 | CANCER SCIENCE | 3044 | 1% | 1% | 43 |
9 | CANCER RESEARCH | 2327 | 3% | 0% | 129 |
10 | VIRCHOWS ARCHIV | 1904 | 1% | 1% | 33 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LYMPHANGIOGENESIS | 2379046 | 13% | 61% | 660 | Search LYMPHANGIOGENESIS | Search LYMPHANGIOGENESIS |
2 | VEGF C | 1110940 | 6% | 63% | 298 | Search VEGF+C | Search VEGF+C |
3 | PODOPLANIN | 924494 | 5% | 66% | 236 | Search PODOPLANIN | Search PODOPLANIN |
4 | CANCER ASSOCIATED FIBROBLASTS | 811140 | 5% | 58% | 236 | Search CANCER+ASSOCIATED+FIBROBLASTS | Search CANCER+ASSOCIATED+FIBROBLASTS |
5 | VEGFR 3 | 643538 | 3% | 70% | 154 | Search VEGFR+3 | Search VEGFR+3 |
6 | VASCULAR ENDOTHELIAL GROWTH FACTOR C | 548801 | 3% | 71% | 130 | Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR+C | Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR+C |
7 | LYMPHATIC ENDOTHELIAL CELLS | 438789 | 2% | 65% | 114 | Search LYMPHATIC+ENDOTHELIAL+CELLS | Search LYMPHATIC+ENDOTHELIAL+CELLS |
8 | VEGF D | 409411 | 2% | 73% | 95 | Search VEGF+D | Search VEGF+D |
9 | PROX1 | 384808 | 2% | 55% | 118 | Search PROX1 | Search PROX1 |
10 | LYVE 1 | 314617 | 2% | 65% | 82 | Search LYVE+1 | Search LYVE+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STACKER, SA , WILLIAMS, SP , KARNEZIS, T , SHAYAN, R , FOX, SB , ACHEN, MG , (2014) LYMPHANGIOGENESIS AND LYMPHATIC VESSEL REMODELLING IN CANCER.NATURE REVIEWS CANCER. VOL. 14. ISSUE 3. P. 159-172 | 137 | 73% | 109 |
2 | DIETERICH, LC , DETMAR, M , (2016) TUMOR LYMPHANGIOGENESIS AND NEW DRUG DEVELOPMENT.ADVANCED DRUG DELIVERY REVIEWS. VOL. 99. ISSUE . P. 148 -160 | 156 | 76% | 6 |
3 | ASPELUND, A , ROBCIUC, MR , KARAMAN, S , MAKINEN, T , ALITALO, K , (2016) LYMPHATIC SYSTEM IN CARDIOVASCULAR MEDICINE.CIRCULATION RESEARCH. VOL. 118. ISSUE 3. P. 515 -530 | 119 | 69% | 11 |
4 | KARPANEN, T , ALITALO, K , (2008) MOLECULAR BIOLOGY AND PATHOLOGY OF LYMPHANGIOGENESIS.ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. VOL. 3. ISSUE . P. 367-397 | 117 | 81% | 189 |
5 | TAMMELA, T , ALITALO, K , (2010) LYMPHANGIOGENESIS: MOLECULAR MECHANISMS AND FUTURE PROMISE.CELL. VOL. 140. ISSUE 4. P. 460-476 | 94 | 64% | 482 |
6 | SLEEMAN, JP , THIELE, W , (2009) TUMOR METASTASIS AND THE LYMPHATIC VASCULATURE.INTERNATIONAL JOURNAL OF CANCER. VOL. 125. ISSUE 12. P. 2747-2756 | 124 | 80% | 102 |
7 | THIELE, W , SLEEMAN, JP , (2006) TUMOR-INDUCED LYMPHANGIOGENESIS: A TARGET FOR CANCER THERAPY?.JOURNAL OF BIOTECHNOLOGY. VOL. 124. ISSUE 1. P. 224-241 | 135 | 89% | 57 |
8 | RAICA, M , RIBATTI, D , (2010) TARGETING TUMOR LYMPHANGIOGENESIS: AN UPDATE.CURRENT MEDICINAL CHEMISTRY. VOL. 17. ISSUE 8. P. 698-708 | 125 | 89% | 16 |
9 | NORRMEN, C , TAMMELA, T , PETROVA, TV , ALITALO, K , (2011) BIOLOGICAL BASIS OF THERAPEUTIC LYMPHANGIOGENESIS.CIRCULATION. VOL. 123. ISSUE 12. P. 1335 -1351 | 130 | 71% | 52 |
10 | SUNDAR, SS , GANESAN, TS , (2007) ROLE OF LYMPHANGIOGENESIS IN CANCER.JOURNAL OF CLINICAL ONCOLOGY. VOL. 25. ISSUE 27. P. 4298 -4307 | 113 | 90% | 66 |
Classes with closest relation at Level 2 |